Despite (or perhaps because of) the volatility in the stock market and uncertainty about the economy, insiders are still ...

Proficio Capital Partners LLC bought a new stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the fourth ...

BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to ...

Sutro Biopharma, a Bay Area oncology biotech company, is laying off around half its staff, switching up its leadership team ...

With a promising outlook for PTC India and Piramal Pharma, Bajaj Broking identifies key stock picks poised for over 15% ...

The Dow Jones and S&P 500 posted robust gains Friday afternoon. Nvidia led the Dow and Ulta topped the S&P 500 on the stock ...

With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling ...

Genmab wisely chose not to pursue GEN3014 further, focusing instead on its existing pipeline projects. Click here to read an ...

EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...